Schwieler J H, Nussberger J, Kahan T, Hjemdahl P
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Am J Physiol. 1994 May;266(5 Pt 2):R1664-9. doi: 10.1152/ajpregu.1994.266.5.R1664.
The overflows (i.e., veno-arterial concentration differences multiplied by plasma flow) of angiotensin-(1-10) decapeptide (ANG I) and angiotensin-(1-8) octapeptide (ANG II) from blood-perfused canine gracilis muscle in situ were studied. Special precautions were taken to minimized ex vivo generation and/or degradation of angiotensins in the sampled blood. ANG I was found to be generated in the catheter system supplying the gracilis muscle with arterial blood, but plasma renin activity and ANG II levels were uninfluenced by the catheter system. A positive venoarterial concentration difference over the muscle itself was found for ANG II but not for ANG I under basal conditions. Isoprenaline elicited vasodilatation, reduced ANG I overflow, and tended to increase ANG II overflow, whereas beta-adrenoceptor blockade by propranolol had no effect on these variables. In conclusion, we found no evidence for a local de novo synthesis of ANG II from the gracilis muscle vasculature in vivo. The net overflow of ANG II was most likely caused by local conversion in the tissue of ANG I artifactually generated in the arterial catheter system. beta-Adrenoceptor stimulation enhanced the local conversion of ANG I to ANG II, probably by exposing a greater endothelial surface containing angiotensin-converting enzyme activity.
研究了在体犬股薄肌经血液灌注后,血管紧张素 -(1 - 10)十肽(ANG I)和血管紧张素 -(1 - 8)八肽(ANG II)的溢出量(即静脉 - 动脉浓度差乘以血浆流量)。采取了特殊预防措施以尽量减少采样血液中血管紧张素的体外生成和/或降解。发现ANG I在为股薄肌供应动脉血的导管系统中生成,但血浆肾素活性和ANG II水平不受导管系统影响。在基础条件下,发现肌肉自身存在ANG II的静脉 - 动脉正浓度差,但ANG I没有。异丙肾上腺素引起血管舒张,降低ANG I溢出量,并倾向于增加ANG II溢出量,而普萘洛尔对β - 肾上腺素能受体的阻断对这些变量没有影响。总之,我们没有发现体内股薄肌血管系统局部从头合成ANG II的证据。ANG II的净溢出很可能是由动脉导管系统中人为生成的ANG I在组织中的局部转化引起的。β - 肾上腺素能受体刺激增强了ANG I向ANG II的局部转化,可能是通过暴露含有血管紧张素转换酶活性的更大内皮表面来实现的。